News

Technology News

Biological Dynamics Bags Series C Venture Funds

Tuesday, November 10, 2015 5:02:00 AM PDT | VentureDeal

   San Diego, California  --  Diagnostic technology company Biological Dynamics has secured $26.8 million in its third round of institutional venture capital funding.

Biological is developing an assay to assist clinicians in evaluating whether a patient undergoing cancer therapy is actually responding to the treatment.

The test only requires a smaller than usual blood sample and results are available within 30 minutes.

Investors in the round included Heritage Group, Alexandria Venture Investments and individual investor Erwin Jacobs.

The company said it would use the proceeds to advance regulatory clearance for its lead oncology diagnostic program.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1